Safety evaluation of an extension of use of the food enzyme endo‐1,4‐β‐xylanase from the genetically modified Bacillus licheniformis strain NZYM‐FX

strain NZYM-FX by Novozymes A/S. The safety of this food enzyme was evaluated previously and it did not give rise to safety concerns when used in two food manufacturing processes. Subsequently, the applicant has requested to extend its use to include two additional processes. In this assessment, EFSA updated the safety evaluation of this food enzyme when used in a total of four food manufacturing processes. As the food enzyme-Total Organic Solids (TOS) are removed in two processes, the dietary exposure to the food enzyme-TOS was estimated for the remaining two food manufacturing processes. It was estimated to be up to 0.024 mg TOS/kg body weight per day in European populations. Based on the new data, the revised dietary exposure and the previous evaluation, the Panel concluded that this food enzyme does not give rise to safety concerns under the revised intended conditions of use.